Ceo
CurrentDue to my semi-retirement, Episentum will terminate the product sales business effective December 31, 2023. I will still be running the company but will from now on only offer expert consulting services within chemistry in a broad sense.Episentum provides signal enhancement products in the form of novel reagents, software, and technologies that significantly improve the performance and broaden the utility of optical biosensors, in particular SPR sensors like e.g. Biacore. The Label-Enhanced Surface Plasmon Resonance (LE-SPR) technology of Episentum improves the sensitivity of SPR sensorgrams 100-fold and makes the sensorgram data 100% specific.www.episentum.com